جست‌وجوی استاد و پژوهشگر

• Vascular Disease
• Diabetes
• Peripheral Neuropathy
• +۵ مورد دیگر

Mark Yorek, PhD is a Professor of Internal Medicine-Endocrinology and Metabolism at the University of Iowa College of Medicine, and Associate Chief of Staff for Research at the Iowa City VA Health System. His work focuses on vascular and neural complications of obesity and diabetes, particularly peripheral neuropathy. He holds a PhD from the University of North Dakota and completed postdoctoral training in Biochemistry at the University of Iowa. Education: PhD, University of North Dakota; Postdoctoral Fellowship, University of Iowa College of Medicine Research interests include mechanisms of vascular dysfunction in diabetes, corneal nerve degeneration as a biomarker for neuropathy, and therapeutic interventions using omega-3 fatty acids and resolvin D1. His studies explore anti-inflammatory and neuroprotective pathways in metabolic diseases. Publications highlight advancements in understanding ATF4's role in muscle atrophy, high-fat diet impacts on neuropathy, and menhaden oil's benefits in preclinical models. Ongoing clinical studies aim to translate these findings into human treatments. Awards: None explicitly listed Dr. Yorek leads the Yorek Lab and collaborates with VA and academic institutions. His research integrates basic science with translational approaches to address metabolic complications, with current emphasis on early neuropathy detection and novel therapies.

Alea Millsمشاهده پروفایل

استاد

• Cancer Biology
• Aging
• Epigenetics
• +۵ مورد دیگر

Alea Mills is a Professor at Cold Spring Harbor Laboratory, leading the Mills Laboratory and serving as Faculty Head of the Animal Shared Resource within the Cancer Center. She is affiliated with the Cancer Center, the Stanley Institute for Cognitive Genomics, and the Gene Regulation and Inheritance departments. Mills earned her Ph.D. in 1997 from the University of California, Irvine. Her research focuses on the genetic and epigenetic mechanisms underlying cancer, aging, and neurodevelopmental disorders like autism. Central to her work is the study of chromatin regulation and its role in diseases such as glioblastoma, squamous cell carcinoma, and senescence. Key projects include investigating the tumor suppressor gene CHD5, the p63 protein family, and chromatin remodeling complexes in cancer progression. Recent publications highlight advancements in glioblastoma treatment through epigenetic reprogramming, the role of ΔNp63α in cancer stemness, and the impact of chromatin modifiers like BRD8 and EZH2. Mills has also contributed to understanding autism using mouse models of 16p11.2 microdeletion. In 2012, she was honored with the 'Woman of the Year in Health/Medicine' award. Her lab collaborates extensively, with a focus on translating basic research into therapeutic strategies. Current efforts include exploring novel targets for cancer and neurodegenerative diseases, alongside investigating the molecular basis of cellular senescence and aging.

Masataka Suzukiمشاهده پروفایل

دانشیار

• Cancer Immunotherapy
• Gene Therapy
• CAR-T Cell Therapy
• +۳ مورد دیگر

Masataka Suzuki is an Associate Professor at Baylor College of Medicine, affiliated with the Center for Gene Therapy and the Dan L Duncan Comprehensive Cancer Center. His research focuses on cancer immunotherapy, particularly combining oncolytic virotherapy with CAR-T cell therapy to target solid tumors. He explores strategies such as cytokine delivery, checkpoint inhibitors, and BiTE molecules to enhance therapeutic efficacy while evaluating tumor immune microenvironments using humanized mouse models. His work emphasizes translational research, including preclinical and clinical studies of ultralow-dose adenoviral vectors. Key projects include in vivo CAR-T cell generation using viral vectors and investigating heterogeneous tumor responses to combination therapies. Publications highlight advancements in modulating immune systems to combat pancreatic tumors and metastatic cancers, demonstrating expertise in viral vector engineering and immunotherapeutic synergy. While no awards or grants are explicitly listed, his contributions to the field are evident through his active research projects and peer-reviewed publications.

Stephen O'Brienمشاهده پروفایل

استاد

• Nanotechnology
• Materials Science
• Energy Storage
• +۴ مورد دیگر

Stephen O'Brien is a Professor of Chemistry and Biochemistry at The City College of New York, affiliated with the Center for Advanced Technology, Chemical Engineering, and the Energy Institute. His research focuses on nanocrystal synthesis, biomedical applications of nanomaterials, batteries, and capacitors, with emphasis on energy storage and clean technology. He leads a research group exploring nanomaterials for applications in photonics, catalysis, and medical devices. His work integrates chemical solution processing and self-assembly techniques to develop high-performance nanocomposites and devices. Key research areas include lithium metal batteries, multiferroic oxides, and meta-capacitor projects. He has pioneered studies on nanoparticle self-assembly and transition metal oxide nanomaterials. His group collaborates on projects funded by various sponsors, aiming to bridge nanotechnology with practical industrial applications. Recent publications span advancements in magnetic sensor design, alkaline battery anodes, and biomedical imaging techniques. He has advised numerous graduate students in materials science and engineering. Notable collaborations include work on fibrotic tissue recovery and biomaterials characterization. His research has implications for sustainable energy systems, medical diagnostics, and nanoscale device fabrication.

Javier F. Medinaمشاهده پروفایل

استاد

• Neural Circuits
• Computational Neuroscience
• Prediction Machines
• +۳ مورد دیگر

Javier F. Medina, Ph.D., is a Professor and Brown Foundation Chair in Neuroscience at Baylor College of Medicine. His research focuses on understanding how neural circuits implement supervised learning to make predictions, particularly in the context of motor control and cognitive functions. His laboratory combines experimental techniques such as electrophysiology, optogenetics, and two-photon imaging with computational modeling and artificial neural networks to uncover the computational principles underlying brain function. Education Postdoctoral Fellowship in Neuroscience, UCSF (2007) Ph.D. in Neuroscience, University of Texas, Houston (2000) Bachelor of Science in Computer Science and Physics, Drexel University, Philadelphia (1993) Research Interests Medina’s work integrates computational neuroscience with experimental approaches to study prediction and error correction in neural circuits. His lab investigates how the cerebellum encodes temporal information, processes sensory input, and adapts through learning. Key topics include supervised learning algorithms, neural coding in Purkinje cells, and the role of prediction errors in motor adaptation. Publications His research spans themes in cerebellar circuitry, motor learning, and computational modeling. Recent work includes deep learning strategies for cell-type identification and studies on cerebellar modules for predictive control. Grants & Labs Medina leads a lab at Baylor College of Medicine, focusing on experimental and theoretical neuroscience. His work has implications for motor disorders linked to learning deficits, such as ataxia and Parkinson’s disease.

Marinko Sarunicمشاهده پروفایل

استاد مدعو

• Biomedical Imaging
• Optical Coherence Tomography
• Microscopy
• +۲ مورد دیگر

Marinko Sarunic is an Adjunct Professor at the School of Engineering Science , Simon Fraser University . He holds a PhD in Biomedical Engineering from Duke University and has been recognized as a Michael Smith Foundation for Health Research Scholar . His research focuses on biomedical imaging , particularly optical coherence tomography (OCT) , microscopy , and low-coherence interferometry , with applications in diabetic retinopathy , Alzheimer’s disease , and age-related macular degeneration . Dr. Sarunic's work spans adaptive optics , deep learning , and sensorless OCT systems , emphasizing clinical translation and open-source software development (e.g., OCTAVA ). His Google Scholar publications highlight multimodal imaging , vascular heterogeneity analysis , and AI-driven diagnostics for retinal diseases. His contributions include the Michael Smith Foundation for Health Research Scholar award. Though not currently teaching courses, his collaborations and leadership in retinal imaging and medical device innovation are pivotal for advancing non-invasive diagnostics in neurodegenerative and diabetic conditions .

• Pharmacology
• Toxicology
• Drug Abuse Research
• +۷ مورد دیگر

Brenda Gannon, Ph.D., is an Assistant Professor in the Department of Pharmacology and Toxicology at the University of Arkansas for Medical Sciences (UAMS), within the College of Medicine. Her research focuses on the abuse-related effects of novel psychoactive substances (NPS), including synthetic cannabinoids, cathinones, and opioids. She also investigates regulatory policy and drug-drug interactions. Dr. Gannon’s work employs behavioral pharmacology techniques such as intravenous self-administration, drug discrimination, and telemetry-based physiological monitoring. Education: Ph.D., Interdisciplinary Toxicology, UAMS (2015) Graduate Certificate in Regulatory Sciences, UAMS (2014) Postdoctoral Fellowship at University of Texas Health Science Center-San Antonio (2015–2018) Research Interests: Dr. Gannon’s research bridges preclinical pharmacology and regulatory science, with emphasis on understanding the neurochemical and behavioral profiles of emerging drugs. Her lab evaluates abuse liability, polypharmacology, and translational strategies for drug development. Key areas include synthetic cathinones, psychedelics, and opioid alternatives. Grant Activity: She serves as Lab Manager (Co-Investigator equivalent) on NIH-funded projects (IDs 15DDHQ24A00000020 and 15DDHQ24A00000027) investigating hallucinogens and stimulants’ abuse potential using in vivo assays. Labs/Teams: Her laboratory focuses on translational drug research, combining behavioral and neurochemical analyses to inform regulatory policy and therapeutic design.

• Metabolic Disorders
• Genetic Variants
• Fatty Liver Disease (FLD)
• +۳ مورد دیگر

Stefano Romeo is a Professor in Molecular and Clinical Medicine at the Sahlgrenska Academy, University of Gothenburg, and a Senior Consultant in Endocrinology at Sahlgrenska University Hospital. He holds a Medical Degree from Campus Biomedico University (2001, Italy) and completed his residency in Endocrinology at Sapienza University of Rome (2006). He has held postdoctoral positions at the University of Texas Southwestern Medical Center (2006–2009) and the University of Cambridge (2009–2011). Affiliations: Wallenberglab, Sahlgrenska University Hospital, and University Magna Graecia (Italy). Research Focus: Genetic determinants of metabolic disorders, including fatty liver disease (FLD) and cardiovascular disease (CVD). Key contributions include identifying PNPLA3 , MBOAT7 , and PSD3 as critical genes in FLD, developing 3D liver models, and pioneering precision medicine approaches. In CVD, he developed a machine-learning algorithm for familial hypercholesterolemia (FH) diagnosis and identified LPL mutations linked to severe hypertriglyceridemia. Clinical Leadership: Director of the Lipid Clinic at Sahlgrenska University Hospital since 2014, focusing on genetic screening for FH and hyperlipidemia management across the Västra Götaland region. Awards & Recognition: International Laureate Chair Prize (2023) Leif Groop Award (2021) Knut and Alice Wallenberg Academy Fellowship (2017) Labs & Teams: Leads a multidisciplinary team including researchers (Rosellina Mancina, Ester Ciociola), postdocs (Kavitha Sasidharan), and students (Tanmoy Dutta). Collaborates with the Lipid Clinic team, including clinicians and residents.

Sarhad Alnajjarمشاهده پروفایل

مدرس

• Veterinary Pathology
• Infectious Diseases
• Zoonotic Diseases
• +۳ مورد دیگر

Dr. Sarhad Alnajjar is a Lecturer in Veterinary Pathology at the University of Surrey's School of Veterinary Medicine, Department of Veterinary Pathology Centre. He holds a Ph.D. in Veterinary Pathology from Iowa State University (USA), with a minor in Microbiology and Immunobiology, and completed a veterinary pathology residency. His prior roles include teaching veterinary pathology at the University of Baghdad. Research focuses on infectious diseases and zoonotic pathogens via a One Health approach. Current projects involve testing antiviral compounds for Respiratory Syncytial Virus (RSV) in neonatal lamb models and developing Human Metapneumovirus models in collaboration with Lambcure LLC and pharmaceutical partners. He has pioneered the neonatal lamb model for RSV research, emphasizing translational therapeutics. Teaching responsibilities include module leadership for VMS2005 and VMS2007 in the second-year veterinary curriculum. He has completed teaching certifications including Iowa State University's Preparing Future Faculty (PFF) and CIRTL programs. Publications span RSV pathogenesis, antiviral efficacy, bacterial coinfections, and veterinary pathology models. His work bridges clinical veterinary medicine with biomedical research, emphasizing animal models for human disease.

Roger J. Colbranمشاهده پروفایل

استاد

• Neuroscience
• Biochemistry
• Synaptic Plasticity
• +۶ مورد دیگر

Roger J. Colbran, PhD, is a Professor and Vice Chair in the Department of Molecular Physiology and Biophysics at Vanderbilt University School of Medicine. His research focuses on calcium/calmodulin-dependent protein kinase II (CaMKII) and its roles in synaptic signaling, neuropsychiatric disorders, and neurological conditions. His lab investigates mechanisms of synaptic plasticity, particularly in the striatum and hippocampus, with implications for learning, memory, and disease. Key affiliations include the Vanderbilt Brain Institute, Vanderbilt Kennedy Center, and Vanderbilt Center for Addiction Research. His work integrates biochemistry, electrophysiology, and proteomics to study CaMKII interactions with receptors (e.g., NMDA, voltage-gated calcium channels) and signaling pathways (e.g., endocannabinoids, phosphatase regulation). Recent articles highlight CaMKII’s role in striatal sociability, nuclear signaling via Shank3 interactions, and ASD-related mutations. His lab’s multidisciplinary approach bridges basic neuroscience with translational research on disorders like addiction and neurodegeneration.

• Oncology
• Neuro-Oncology
• Hematology
• +۵ مورد دیگر

Radu O. Minea is an Assistant Professor of Research in Neurological Surgery at the University of Southern California (USC). His research focuses on developing conjugated drug therapies for cancers such as glioblastoma, leukemia, and lymphoma. He specializes in preclinical models to evaluate the efficacy of novel compounds like NEO212, NEO214, and NEO100, which target cancer cells through mechanisms including autophagy inhibition, macrophage differentiation, and enhanced drug delivery to tumor sites. His work bridges molecular oncology, drug design, and translational medicine, with a particular emphasis on overcoming drug resistance in malignant tumors. Key research areas include: Design and testing of conjugated chemotherapeutic agents Mechanisms of drug resistance in gliomas and hematologic malignancies Targeted drug delivery strategies for brain-localized cancers Role of disintegrins and venom-derived peptides in cancer therapy Dr. Minea’s publications highlight innovations in radiosensitization, antiviral cancer therapies, and the application of multi-integrin targeting proteins. His research has implications for improving treatment outcomes in aggressive cancers like glioblastoma and acute myeloid leukemia.

• Pulmonary Research
• Lung Development
• Bronchopulmonary Dysplasia
• +۵ مورد دیگر

Parviz Minoo, PhD is a Professor of Pediatrics at the Keck School of Medicine, University of Southern California, where he also serves as Director of the USC Hastings Center for Pulmonary Research. His research focuses on pulmonary development and disease, with particular emphasis on understanding the molecular mechanisms underlying lung morphogenesis and alveolar development. Dr. Minoo's research interests center on pulmonary biology with a focus on lung development, alveologenesis, and bronchopulmonary dysplasia. His work investigates the complex signaling pathways involved in lung formation, including Wnt, FGF, TGF-β, and Hedgehog signaling networks. He has made significant contributions to understanding how transcription factors like NKX21 regulate lung epithelial cell differentiation and how growth factors such as FGF10 drive alveolar formation. His research bridges basic developmental biology with clinical applications for neonatal respiratory disorders. Analysis of Dr. Minoo's recent publications reveals a consistent focus on the molecular mechanisms of alveologenesis and lung regeneration. His work demonstrates how specific signaling pathways (Wnt5a, FGF10, Hedgehog) interact with transcription factors (NKX21, FOXO1) to regulate alveolar cell differentiation. The research spans from fundamental developmental biology to potential therapeutic applications for bronchopulmonary dysplasia and pulmonary fibrosis, with increasing attention to cellular plasticity, progenitor cell niches, and the role of the extracellular matrix in lung development. As Director of the USC Hastings Center for Pulmonary Research, Dr. Minoo oversees a multidisciplinary team investigating lung development, injury, and repair mechanisms. His laboratory employs sophisticated mouse models, organoid cultures, and molecular techniques to unravel the complexities of pulmonary biology. The center serves as a hub for collaborative research connecting basic science with clinical applications in neonatal and pediatric pulmonary medicine.

• Cognitive Psychology
• Decision Making
• Neural Modeling
• +۳ مورد دیگر

Tobias Grage is a Researcher affiliated with the Department of Psychology at Technische Universität Dresden, within the Faculty of Science. His work is conducted at the Institute of General Psychology, Biopsychology and Methods of Psychology. Grage holds a Diploma in Psychology from TU Dresden (2014) and completed his PhD there since May 2015 under the supervision of Jun.-Prof. Dr. Stefan Scherbaum. He previously earned a degree in Cognitive Science from Osnabrück University (2006-2008). His research focuses on control dilemmas, specifically investigating the interplay between shielding and shifting control functions. He employs dynamic neural field models alongside empirical measures like mouse tracking to identify meta-control parameters governing decision-making dynamics. Grage has contributed to subproject A8 and has held roles such as research assistant under Dr. Stefan Scherbaum and Dr. Matthias Rudolf, as well as tutoring in cognitive neuropsychology and statistics at Osnabrück University. His publications emphasize methodological rigor in mouse-tracking studies, exploring how design factors influence behavioral and cognitive inferences. Grage’s work bridges cognitive psychology, neuroscience, and empirical methodology, addressing both theoretical and applied aspects of decision processes and neural dynamics.

Asolina Braunمشاهده پروفایل

پژوهشگر ارشد

• Skin Immunology
• Autoimmunity
• Psoriasis
• +۷ مورد دیگر

Dr. Asolina Braun is a Senior Research Fellow at the Department of Biochemistry & Molecular Biology, Monash University. She actively supervises PhD students and contributes to research in Skin Immunology Psoriasis Pathogenesis Immunopeptidomics Tissue-Resident Memory T Cells . Education : Biology, Hannover Medical School Doctoral Degree in Immunology (Hannover Medical School, Germany, 2011–2014) Postdoctoral Fellowship with Francis Carbone and Thomas Gebhardt (Germany, 2014–2018) Research Focus : Her work explores HLA-Cw6-dependent antigen presentation and TRM cell survival factors in psoriasis, aiming to develop tolerization strategies for autoinflammatory skin diseases. She also pioneered tactile science communication methods for psoriasis outreach. Key Projects : Leading Psoriasis Antigen Triggers (2023–2025) Investigating Influenza Immune Cross-Protection (2024–2027) Validating HLA-Cw6 Antigen Presentation (2020–2022) Awards & Roles : DFG Fellowship Treasurer, Australian and New Zealand Society for Immunology (2018–2022) Executive Committee Member Collaborations span institutions in Australia, Germany, and Denmark, with expertise in flow cytometry , mass spectrometry , and MHC-peptide interactions .

Christoph Hagemeyerمشاهده پروفایل

استاد

• Drug Delivery
• Molecular Imaging
• Thrombosis
• +۴ مورد دیگر

Christoph Hagemeyer is a Professor at Monash University’s Australian Centre for Blood Diseases and Head of the NanoBiotechnology Laboratory. He holds dual affiliations with Monash Biomedical Imaging and the Victorian Heart Institute. His academic roles include teaching in the Central Clinical School’s Honours program, focusing on molecular imaging technology and cardiovascular pathology. Hagemeyer earned his PhD in Biochemistry from Albert Ludwigs University of Freiburg, Germany (2001), and an MSc in the same field (1997). His research emphasizes drug delivery, molecular imaging, and nanotechnology applications in thrombosis, inflammation, and cancer. He leads major projects including the ARC Training Centre for Advanced Radiochemical Technologies (2024–2029) and the CASS Foundation’s targeted thrombolytic nano-carrier initiative (2023–2027). Awards include NHMRC Senior Research Fellowship (2019–2023) and leadership as ASMR President since 2019. His work aligns with UN SDGs through advancements in medical diagnostics and therapies. Recent research outputs span nanocarrier development, cardiac fibrosis imaging, and insulin analog synthesis. His lab utilizes facilities like the Near Infrared Fluorescence and Photoacoustic Imaging Facility. Collaborations span global institutions, with active editorial roles in Cardiovascular Therapeutics and PLoS ONE .